BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Ilan’s innovation strategy sets it on a journey with Sheba Medical Center, from the lab bench and clinical research to ...
The Centre for DNA Fingerprinting and Diagnostics Hyderabad invites online applications for Scientist-III and Scientist-IV ...
A biotech start-up says the ovaries may hold clues to aging — a finding that could reshape IVF while opening a frontier in ...
Nevada ranchers will have multiple opportunities this January to hear directly from university specialists, veterinarians, ...
Where do the well-known cannabis compounds THC, CBD and CBC come from? Researchers at Wageningen University & Research have experimentally ...
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...
Vanessa Bates Ramirez is a science and technology journalist focused on energy, climate technology, artificial intelligence ...
An FDA decision will extend the timeline for possible approval of Inovio's lead new drug candidate, a therapy that could ...
Two phase III studies of setrusumab, Orbit and Cosmic, for treating brittle bones have failed and left the developers floundering on Wall Street. Neither of Ultragenyx Pharmaceutical Inc. and Mereo ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will participate in and sponsor the 10(th) Annual MASH-TAG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback